Dr. Bradley Thomas Clifford, MD

Dr. Clifford practices at Summa Health System - Akron Campus in Akron, Ohio, part of General Catalyst.

Dr. Clifford's NPI, 1346458650, was assigned on May 18, 2007. Dr. Clifford holds Ohio license 35092846.

Dr. Clifford's primary practice is Summa Health System - Akron Campus, at 525 East Market Street, Akron, OH 44309 in Summit County. The practice phone is (330) 375-3000.

Dr. Clifford's primary practice is Summa Health System - Akron Campus in Akron, Ohio, part of General Catalyst. The medical group on file is Summa Health Medical Group. Dmand AI also links Dr. Clifford to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Clifford practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Clifford's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Clifford is licensed in Ohio.

CMS data shows 746 Medicare services from Dr. Clifford across 8 procedure codes in 2024, for 277 Medicare patients. Medicare paid $58,276 for them.

CMS counts 277 Medicare patients who saw Dr. Clifford in 2024. The largest group is 65 to 74, with 133 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Clifford's median patient age at 70, with 71% women.

In 2024, Dr. Clifford wrote 2,754 Medicare Part D claims for 454 patients. 81% of them were for generic drugs. CMS names the drug for 2,609 of them, across 41 drugs with 11 or more claims each, at $6,181,770 in total drug cost. In 2023, CMS named 2,357 claims across 44 drugs.

Dr. Clifford accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Clifford as offering telehealth.

Dmand AI links 2 papers to Dr. Clifford, published from 2012 to 2021. Dr. Clifford's most frequent co-authors are Elaine O. Bigelow, MD, Jimmy Caudell, MD and Yuhchyau Chen, MD.

Dmand AI links Dr. Clifford to 10 clinical trials, 6 of them phase 3 studies. 7 are still active or recruiting. Conditions studied include Carcinoma, Bronchogenic, Breast Carcinoma In Situ and Carcinoma, Non-Small-Cell Lung. National Cancer Institute (NCI) sponsors the most, 10.

CMS Open Payments shows 25 general payments to Dr. Clifford from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Merck Sharp & Dohme Corporation paid the most, $125.